Table 3.
Incidence of OIs in the Global Cohort and in the New HIV Infections Subset
| Global Cohort | |||||||
|---|---|---|---|---|---|---|---|
| All Cases | Unknown CD4a | <100 CD4a | <200 CD4a | <350 CD4a | ≥350 CD4a | ||
| TB | Cases/No. screened | 137/1701 | 46/518 | 51/343 | 70/572 | 80/843 | 11/340 |
| Incidence, % | 8.1 | 8.9 | 14.9 | 12.2 | 9.5 | 3.2 | |
| NTM | Cases/No. screened | 16/1701 | 2/518 | 6/343 | 8/572 | 11/843 | 3/340 |
| Incidence, % | 0.9 | 0.4 | 1.7 | 1.4 | 1.3 | 0.9 | |
| H | Cases/No. screened | 120/1850 | 45/569 | 55/368 | 65/615 | 73/910 | 2/371 |
| Incidence, % | 6.5 | 7.9 | 15.0 | 10.6 | 8.0 | 0.5 | |
| C | Cases/No. screened | 76/1732 | 16/530 | 38/336 | 52/568 | 56/853 | 4/349 |
| Incidence, % | 4.4 | 3.0 | 11.3 | 9.2 | 6.6 | 1.1 | |
| Total incidence, % | 19.9 | 20.2 | 42.9 | 33.4 | 25.4 | 5.7 | |
| Newly HIV infections | |||||||
| All Cases | Unknown CD4a | <100 CD4a | <200 CD4a | <350 CD4a | ≥350 CD4a | ||
| TB | Cases/No. screened | 55/825 | 15/180 | 25/207 | 31/332 | 36/485 | 4/160 |
| Incidence | 6.7 | 8.3 | 12.1 | 9.3 | 7.4 | 2.5 | |
| NTM | Cases/No. screened | 5/825 | 1/180 | 2/207 | 4/332 | 4/485 | 0/160 |
| Incidence | 0.6 | 0.6 | 1.0 | 1.2 | 0.8 | 0.0 | |
| H | Cases/No. screened | 65/872 | 21/186 | 36/220 | 41/352 | 44/516 | 0/170 |
| Incidence | 7.5 | 11.3 | 16.4 | 11.6 | 8.5 | 0.0 | |
| C | Cases/No. screened | 34/840 | 7/187 | 20/201 | 24/328 | 26/489 | 1/164 |
| Incidence | 4.0 | 3.7 | 9.9 | 7.3 | 5.3 | 0.6 | |
| Total incidence | 18.8 | 24.0 | 39.4 | 29.4 | 22 | 3.1 |
Abbreviations: C, cryptococcosis; H, histoplasmosis; NTM, nontuberculous mycobacteria; OI, opportunistic infection; TB, tuberculosis.
aNumber of CD4 cells/mm3.